Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1931 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | IL-16 | 41.5 | 74 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 1 | IL-16 | 50.0 | 51 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | IL-16 | 126.5 | 48 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-16 | 43.0 | 56 | |
RA1869 | TNF-a | 100 | ng/mL | 1 | IL-16 | 40.5 | 48 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-16 | 368.0 | 48 | |
N2759 | TNF-a | 100 | ng/mL | 1 | IL-16 | 304.0 | 50 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-16 | 84.0 | 55 | |
RA1931 | TNF-a | 100 | ng/mL | 1 | IL-16 | 93.5 | 52 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-16 | 177.0 | 30 | |
N2586 | TNF-a | 100 | ng/mL | 1 | IL-16 | 220.0 | 47 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-16 | 27.0 | 55 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-16 | 23.0 | 61 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-16 | 58.5 | 50 | |
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-16 | 102.5 | 54 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-16 | 24.0 | 42 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-16 | 32.0 | 59 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-16 | 51.0 | 62 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-16 | 55.0 | 53 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-16 | 35.5 | 52 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 1 | IL-16 | 33.0 | 54 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-16 | 151.5 | 56 | |
N2759 | IL-1 alpha | 100 | ng/mL | 1 | IL-16 | 140.0 | 29 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-16 | 58.0 | 48 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 1 | IL-16 | 40.0 | 47 |